# Mangoceuticals, Inc. (MGRX)

> Healthcare · US · Reports in USD

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/MGRX/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2025 | $ 466.9K | $ -21.14M | $ -5.99M | $ 307.8K | $ 15.20M |
| 2024 | $ 647.3K | $ -9.15M | $ -5.11M | $ 215.0K | $ 13.95M |
| 2023 | $ 790.9K | $ -9.96M | $ -7.57M | $ 128.7K | $ 774.8K |
| 2022 | $ 10.0K | $ -2.25M | $ -1.55M | $ 352.9K | $ 614.0K |
| 2021 | $ 0 | $ -21.0K | $ -20.8K | N/A | N/A |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Gross Debt / Eq | 0.02 |
| Liabilities / Eq | 0.06 |
| Current Ratio | 1.74 |

## Other views

- [Metrics](https://sponda.capital/en/MGRX.md)
- [Charts](https://sponda.capital/en/MGRX/charts.md)
- [Compare](https://sponda.capital/en/MGRX/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-27.